trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Too much cholesterol in the blood can stick to the walls of the arteries and narrow or even block them.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that too much cholesterol in the blood can stick to the walls of the arteries and narrow or even block them?

Yes. Excess circulating cholesterol and atherogenic lipoproteins accumulate in arterial walls, driving the formation and progression of atherosclerotic plaques that narrow or block blood vessels.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The claim describes the well-established pathological mechanism of atherosclerosis, where excess blood cholesterol and lipoproteins infiltrate the arterial intima, leading to plaque buildup and vascular narrowing. Multiple retrieved reviews (e.g., papers 3, 5, 6, and 8) consistently support this mechanism, linking lipid retention and dyslipidemia directly to atherogenesis and plaque formation.

Evidence for · 4
Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant-Based Therapies: A Narrative Review.
2026
Identifies atherosclerosis—characterized by lipid retention and plaque accumulation in arteries—as the primary pathological basis of ischemic cardiovascular disorders.
Get citation
NH, S., UH, M., SA, T., H, S., AB, M., F, N., J, I., N, T., & MMI, C. (2026). Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant-Based Therapies: A Narrative Review.. doi.org. https://doi.org/10.1002/hsr2.73102

See more details
More for · 3
Clinical utility of lipoprotein(a) and the ApoB/ApoA-I ratio in the risk assessment of acute coronary syndrome: from single biomarkers to integrated risk stratification.
2026
Highlights dysregulated lipid metabolism and atherogenic lipoprotein particles as central drivers of coronary atherosclerotic plaque formation and clinical complications.
Get citation
Z, L., P, L., R, L., X, G., S, L., & J, W. (2026). Clinical utility of lipoprotein(a) and the ApoB/ApoA-I ratio in the risk assessment of acute coronary syndrome: from single biomarkers to integrated risk stratification.. doi.org. https://doi.org/10.3389/fcvm.2026.1937328

Targeting lymphatic dysfunction in atherosclerosis: a state-of-the-art review on potential therapies and future directions.
2026
Notes that plaque accumulation involves lipid accumulation alongside endothelial dysfunction and inflammation within the vessel wall.
Get citation
A, V., A, M., B, S., S, A., V, T., & J, V. (2026). Targeting lymphatic dysfunction in atherosclerosis: a state-of-the-art review on potential therapies and future directions.. doi.org. https://doi.org/10.3389/fcvm.2026.1774468

Endothelial Cells at the Crossroad of Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Unifying Target for Dual Treatment.
2026
Discusses how vascular endothelial dysfunction facilitates lipoprotein retention and plaque formation inside arteries.
Get citation
C, B. D., O, R., & AW, O. (2026). Endothelial Cells at the Crossroad of Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Unifying Target for Dual Treatment.. doi.org. https://doi.org/10.1016/j.jacbts.2026.101624

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work